Attenuation of cysteinyl leukotrienes induces human mesenchymal stem cell differentiation

Wound Repair and Regeneration

Volumn 14, Issue 3, 2006, Pages 343-349

  Akino, Kozo ^a   Mineda, Takao ^a   Mori, Nozomu ^a   Hirano, Akiyoshi ^a   Imaizumi, Toshifumi ^a   Akita, Sadanori ^a  

^a NAGASAKI UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; CYSTEINYLLEUKOTRIENE TYPE 1 RECEPTOR; CYSTEINYLLEUKOTRIENE TYPE 1 RECEPTOR ANTAGONIST; FIBRONECTIN; PEPTIDOLEUKOTRIENE; PRANLUKAST; UNCLASSIFIED DRUG;

ARTICLE; ATTENUATION; BONE MARROW CELL; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; CYTOPLASM; DOSE RESPONSE; ENDOPLASMIC RETICULUM; FRACTURE; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VIVO STUDY; INCUBATION TIME; LUNG FIBROSIS; MESENCHYMAL STEM CELL; MICROVILLUS; PRIORITY JOURNAL; REPERFUSION INJURY; SKIN INJURY;

CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; CHROMONES; CYSTEINE; FEMALE; FIBRONECTINS; HUMANS; IMMUNOHISTOCHEMISTRY; LEUKOTRIENE ANTAGONISTS; LEUKOTRIENES; MEMBRANE PROTEINS; MESENCHYMAL STEM CELLS; RECEPTORS, LEUKOTRIENE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 33745529512     PISSN: 10671927     EISSN: 1524475X     Source Type: Journal    
DOI: 10.1111/j.1743-6109.2006.00130.x     Document Type: Article

References (16)

1. Ogasawara H, Ishii S, Yokomizo T, Kakinuma T, Komine M, Tamaki K, Shimizu K, Izumi T. Characterization of mouse cysteinyl leukotriene receptors mCysLT1 and mCysLT2. Differential pharmacological properties and tissue distribution. J Biol Chem 2002; 277: 18763-8.
2. Obata T, Okada Y, Motoishi M, Nakagawa N, Terawaki T, Aishita H. In vitro antagonism of ONO-1078, a newly developed anti-asthma agent, against peptide leukotrienes in isolated guinea pig tissues. Jpn J Pharmacol 1992; 60: 227-37.
3. Samuelsson B, Dahlen SE, Lindgren JA, Rouzer CA, Serhan CN. Leukotrienes and lipoxins: structures, biosynthesis, and biological effects. Science 1987; 237: 1171-6.
4. Chibana K, Ishii Y, Asakura T, Fukuda T. Up-regulation of leukotriene 1 receptor by IL-13 enables human lung fibroblasts to respond to leukotriene C4 and produce eotaxin. J Immunol 2003; 170: 4290-5.
5. Beller TC, Friend DS, Maekawa K, Lam BK, Austen KF, Kanaoka Y. Cysteinyl leukotriene 1 receptor controls the severity of chronic pulmonary inflammation and fibrosis. Proc Natl Acad Sci 2004; 101: 3047-52.
6. Ortiz LA, Gambelli F, McBride C, Gaupp D, Baddoo M, Kaminski N. Mesenchymal stem cell engraftment in lung is enhanced in response to bleomycin exposure and ameliorates its fibrotic effects. Proc Natl Acad Sci 2003; 100: 8407-11.
7. Parameswaran K, Watson R, Gauvreau GM, Sehmi R, O'Byrne PM. The effect of pranlukast on allergen-induced bone marrow eosinophilopoiesis in subjects with asthma. Am J Respir Crit Care Med 2004; 169: 915-20.
8. Bandiavas EV, Abedi M, Butmarc J, Falanga V, Quesenberry P. Participation of bone marrow derived cells in cutaneous wound healing. J Cell Physiol 2003; 196: 245-50.
9. Akino K, Mineta T, Fukui M, Fujii T, Akita S. Bone morphogenetic protein-2 regulates proliferation of human mesenchymal stem cells. Wound Rep Reg 2003; 11: 354-60.
10. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162: 156-9.
11. Parameswaran K, Liang H, Fanat A, Watson R, Snider DP, O'Byrne PM. Role for cysteinyl leukotrienes in allergen-induced change in circulating dendritic cell number in asthma. J Allergy Clin Immunol 2004; 114: 73-9.
12. Machida I, Matsuse H, Kondo Y, Kawano T, Saeki S, Tomari S, Obase Y, Fukushima C, Kohno S. Cysteinyl leukotrienes regulate dendritic cell functions in a murine model of asthma. J Immunol 2004; 172: 1833-8.
13. Akita S, Fukui M, Nakagawa H, Fujii T, Akino K. Cranial bone defect healing is accelerated by mesenchymal stem cells induced by coadministration of bone morphogenetic protein-2 and basic fibroblast growth factor. Wound Rep Reg 2004; 12: 252-9.
14. Devine MJ, Mierisch CM, Jang E, Anderson PC, Balian G. Transplanted bone marrow cells localize to fracture callus in a mouse model. J Orthop Res 2002; 6: 1232-9.
15. Wang L, Li Y, Chen J, Gautam SC, Zhang Z, Lu M, Chopp M. Ischemic cerebral tissue and MCP-1 enhance rat bone marrow stromal cell migration in interface culture. Exp Hematol 2002; 30: 831-6.
16. Yamamoto T, Takagawa S, Katayama I, Nishioka Anti-sclerotic effect of transforming growth factor-β antibody in a mouse model of bleomycin-induced sceleroderma. Clin Immunol 1999; 92: 6-13.